Advertisement

Topics

Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

09:00 EST 7 Dec 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Novel Prodrug with Unique Mechanism of Action Takes on the Opioid Crisis Concentric Analgesics, Inc., a clinical-stage biopharmaceutical pain company, announced today that the U.S. Food and Drug Administration (FDA) h...

Other Sources for this Article

Investors:
Concentric Analgesics
Frank Bellizzi
CFO
frank@concentricanalgesics.com
or
Media:
Kinkead Communications
Susan Kinkead, 415-509-3610
susan@kinkeadcomm.com

NEXT ARTICLE

More From BioPortfolio on "Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...